This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.

US District Court: Eastern District of New York - In re vitamin C antitrust litigation [opposition to permanent injunction]

( May 13, 2013, 16:17 GMT | Official Statement) -- MLex Summary: Gebei Welcome Pharmaceutical and North China Pharmaceutical Group have filed an opposition to plaintiffs' motion for permanent injunction stating injunction is a drastic remedy. Defendants argue plaintiffs' have not suffered irreparable harm, there are other less-drastic remedies available, and the injunction would interfere with the Chinese Government's sovereignty....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections